MAPK3 and cancer: ErbB/HER RTKs have been implicated in promoting cancer cell survival in response to radiation, which is likely to involve the following two mechanisms: (1) inducing the prosurvival AKT and ERK1/2 signaling pathways [45,46] (Figure 3), and (2) facilitating cell cycle checkpoint response to promote DNA repair [49,50].